The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users ...

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users cite weight loss as their main goal. But weight loss doesn't discriminate ...

As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity for weight loss, doctors are observing a ...

Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders.

Oprah Winfrey has been slammed for her controversial comments about 'thin people' while discussing her use of weight loss ...

Colorado plans to start limiting insurance coverage of prescription weight-loss drugs for its roughly 40,000 state employees, a cost-cutting measure in a difficult budget year that officials say will ...

Discover how Oprah Winfrey's experience with GLP-1 medications like Ozempic reshaped her understanding of weight loss and ...

All these years I thought that thin people — those people — just had more willpower,” Winfrey said on her podcast.

Allurion Technologies (ALUR) announced its intention to initiate a clinical study on the combination of the Allurion Program with GLP-1 ...

On the latest episode of her podcast, Oprah Winfrey opened up about how her opinion of “thin people” changed after she was able to lose weight herself with the help of weight loss medications.

Shantanu Gaur, the founder and chief executive of Allurion, said the goal of the study would be to prove that combining the Allurion Balloon and Allurion Virtual Care Suite with GLP-1 therapy would ...